Home / Healthcare-IT / Obesity- P

Obesity- Pipeline Insights, Recent Developments, Major Players and Review

Obesity: Overview

Obesity is a body condition in which a person's weight is above the normal range. It's an illness that can lead to a slew of additional issues. Obesity is observed when a particular person consumes more calories than their body demands. These extra set of calories that are stored as body fat. The amount of body fat you retain and where that fat is distributed may be influenced by the genes you receive from your parents. If the doctor collaborates with a team of professionals, such as psychologists, nutritionists, and exercise specialists, the incidences of long-term sustainable weight loss cases have increased in recent times.

As per the findings of World Health Organization, the world has more than 2 billion overweight adults living in different regions and out of them 650 million are categorized as obese. Although there are genetic, behavioural, metabolic, and hormonal influences on body weight, obesity generally develops when one takes more calories than the actual requirement for the body. In the developed regions of the world, a large section of the population has a high calorie intake due to the consumption of high calorie beverages and fast food.

Report Key Takeaways

Recommended Prevention and Treatment Options for Obesity:

Liraglutide

Liraglutide is among the commonly used medication to treat diabetes. Liraglutide, unlike other weight-loss medications, is administered through injection. Nausea is a very common ailment. Its use may be limited if you vomit.

Phentermine-topiramate

Phentermine-topiramate is a weight-loss medication that also acts as an anticonvulsant. An increase in heart rate and blood pressure, sleeplessness, constipation, and nervousness are all possible side effects.

Orlistat

Orlistat can be accessible without need for a prescription but if it is in a reduced-strength variant. Loose stools and flatulence are adverse effects that are associated with the orlistat. Orlistat has been linked to a small number of significant liver injuries.

Recent Developments Related to Obesity

  • At the 82nd annual scientific sessions of American Diabetes Association, Zealand Pharma has officially published the reports from the Dapiglutide Phase 1 Trial that was held on June 6 2022. After this presentation, the company has announced that Dapiglutide will tested in the Phase 2 Obesity Trial.
  • Tirzepatide, is licenced by the US Food and Drug Administration in May for the treatment of Type 2 diabetes. The experimental drug developed by US Pharma Company called Eli Lilly has also been hailed as an alternative to bariatric surgery. According to a study, using a medicine once a week can result in significant and long-term weight loss.

Major Players Working on Obesity

Leading companies such as Allysta Pharmaceuticals, Pfizer, Novo Nordisk, Vivus Pharmaceuticals, Empros Pharma, Boehringer Ingelheim, Lobesity Pharma, and GlaxoSmithKline are working rigorously to provide effective obesity management solutions. The FDA has approved Eli Lilly's diabetic medicine Mounjaro, a first-of-its-kind treatment that can help patients control their blood sugar while also potentially assisting them in losing weight.

 

Key Reasons to Purchase This Report

  • The pipeline insight features an in-depth global outlook of the modern therapies that are under different phases of development and future potential for working on the obesity pipeline.
  • A broader overview of leading companies that are involved in the development of advanced drugs/treatment solutions and their recent activities in the pipeline domain.

A comparative analysis of different obesity products which are under clinical and non-clinical phases, along with an assessment of probable risks and prevailing opportunities in the respective pipeline landscape.

Some of the most commonly observed obesity symptoms are excess body fat, snoring, fatigue, shortness of breath, body pain, skin problems, and psychological issues.

High blood pressure, stroke, asthma, high cholesterol, type-2 diabetes, sleep apnea, and osteoarthritis are some of the complications that can develop in obese people.

Obesity is caused by eating too much and/or not exercising enough. In addition to this, there are other factors such as genetics and environment also play a role in obesity.

A person's BMI is a general estimate of their weight in relation to their height. Other more precise body fat distribution measurements include: ultrasounds, MRI scans, and skinfold thickness tests.

Surgery is only recommended when all other weight management methods fail to reduce that weight. Any individual who has a BMI level of more than 32.5 kg/sq. can benefit from the procedure. Even people who are 25 kg overweight are good candidates and will get significant results from the treatment.

Choose License Type
Published Date:  Jun 2022
Category:  Healthcare-IT
Report ID:   60560
Report Format:   PDF
Pages:   90
Rating:    4.5 (16)
Connect With Us
+1-408-641-3282
24/7 Research Support